Connect with us

Technology

3D Printing Medical Devices Market size is set to grow by USD 7.07 billion from 2024-2028, Increased demand for personalized or customized medical devices boost the market, Technavio

Published

on

NEW YORK, July 30, 2024 /PRNewswire/ — The global 3D printing medical devices market size is estimated to grow by USD 7.07 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 25.2%  during the forecast period. Increased demand for personalized or customized medical devices is driving market growth, with a trend towards rising focus on the research for the use of 3D printing process to manufacture living organs and cell structures. However, high initial setup cost of 3d printing facility  poses a challenge. Key market players include 3D Systems Corp., Anatomics Pty Ltd., Autodesk Inc., Biomerics LLC, Boston Scientific Corp., Desktop Metal Inc., EOS GmbH, Exail Technologies, Formlabs Inc., General Electric Co., INTAMSYS TECHNOLOGY CO. LTD., MATERIALISE NV, Mecuris GmbH, Medtronic Plc, Organovo Holdings Inc., Qualtech Consulting Corp., Renishaw Plc, Schultheiss GmbH, SLM Solutions Group AG, and Stratasys Ltd..

Get a detailed analysis on regions, market segments, customer landscape, and companies- View the snapshot of this report

3D Printing Medical Devices Market Scope

Report Coverage

Details

Base year

2023

Historic period

2018 – 2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 25.2%

Market growth 2024-2028

USD 7079.6 million

Market structure

Fragmented

YoY growth 2022-2023 (%)

19.78

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 40%

Key countries

US, Germany, UK, Japan, and China

Key companies profiled

3D Systems Corp., Anatomics Pty Ltd., Autodesk Inc., Biomerics LLC, Boston Scientific Corp., Desktop Metal Inc., EOS GmbH, Exail Technologies, Formlabs Inc., General Electric Co., INTAMSYS TECHNOLOGY CO. LTD., MATERIALISE NV, Mecuris GmbH, Medtronic Plc, Organovo Holdings Inc., Qualtech Consulting Corp., Renishaw Plc, Schultheiss GmbH, SLM Solutions Group AG, and Stratasys Ltd.

Market Driver

The 3D printing of medical devices, specifically in the field of bioprinting, represents a significant advancement in healthcare technology. This process involves the precise layering of cells, biologic scaffolds, and growth factors to create bioidentical tissue, such as stem cells, skin grafts, and bone and cartilage. Unlike traditional 3D printers that use plastic or metals as raw materials, 3D bioprinters utilize a computer-guided pipette to layer living cells, referred to as bioink, to create artificial living tissues. One of the most promising applications of 3D bioprinting is in organ replacement. This technology holds the potential to address the organ donor shortage and reduce rejections by creating organs that better meet the requirements of the body. For instance, 3D printed bone features a micropore surface that allows osteocytes to adhere, join, and heal better than traditional metal implants. ORGANOVO, a biotechnology company, is pioneering the use of 3D bioprinting to develop in vivo liver tissues for treating rare, life-threatening diseases. Their product, the ExVive 3D Bioprinted Human Liver Tissues, can be used for drug exposure and metabolism studies, offering a valuable alternative to organ transplantation. Allevi and SHIBUYA are among the companies leading the way in 3D bioprinting technology. Allevi introduced the first desktop 3D bioprinter capable of printing living tissues using human cells, while SHIBUYA’s 3D bioprinter is the first cell culture system for building complex cell-based structures. The potential of 3D bioprinting is driving increased R&D efforts in developing devices for this technology. As technological advances continue, 3D printing medical devices are expected to see widespread adoption, fueling the growth of the global 3D printing medical devices market. 

The 3D Printing Medical Devices market is experiencing significant growth due to its ability to produce customized, patient-specific solutions for various medical applications. Stereolithography (SLA) and digital light processing are popular 3D printing technologies used in creating prosthetics implants, orthopedic implants, and wearable medical devices. Dentistry and orthodontics also benefit from 3D printing, with applications including dentures, bone scaffolds, and hearing aids. Tissue-engineered products, remote patient monitoring, telemedicine, and vital signs monitoring are other areas where 3D printing is making an impact. Complex medical procedures, such as implantable and non-implantable medical devices, drug testing, and organ and tissue production, are also being revolutionized by this technology. Computer-aided manufacturing and design, diagnostic centers, medical institutions, and 3D printing laboratories are embracing 3D printing to provide personalized solutions. Laser beam technology, minimally invasive surgery, and surgical equipment are other areas where 3D printing is making a difference. Patient CAD images are used to create patient-specific models and customized implants, including cranial implants for neurosurgery and human skull repairs. Overall, 3D printing is transforming the medical industry by enabling the production of customized, high-quality medical devices in a layer-wise manner. 

Discover 360° analysis of this market. For complete information, schedule your consultation – Book Here!

Market Challenges

The 3D printing medical devices market faces significant challenges due to high capital costs. Equipment for 3D printing or outsourced print service contracts, advanced software for post-processing, and proprietary raw materials contribute to these costs. Desktop FDM or SLA machines cost less than USD5,000, but high-end additive manufacturing printers range from USD200,000 to USD850,000 or even millions. Skilled personnel and training are also necessary, adding to the expenses. A clinical 3D printing lab requires ancillary staff for printing. Production time, ranging from hours to days, limits its use in mass manufacturing. These factors hinder the widespread adoption of 3D printers, potentially impacting the growth of the market negatively.The 3D printing medical devices market is experiencing significant growth due to the advantages it offers in creating customized solutions for various medical needs. However, there are challenges that need to be addressed. For physicians, the use of 3D-printed medical devices in elective surgical procedures requires careful consideration for complex prosthetic limbs and brain designs. Surgeons prefer titanium alloys for surgical tools, but cancer patients benefit from biocompatible materials as drug contact materials. Hearing aid manufacturers are exploring 3D-printed hearing aid devices using biocompatible materials for personalized solutions. CAD/CAM technology and desktop printers are revolutionizing dental clinics and hospitals, providing dental restoration, surgical planning, and personalized prosthetics. Orthopedic prosthetics and surgical instruments also benefit from 3D printing, improving surgical outcomes, operation time, and reducing post-surgical complications. Mechanical protection for tissues and organs is a promising area for 3D printing, with potential applications in organ transplantation and living cells using biomaterials. However, biosafety concerns and ethical issues surrounding the use of human cells and tissues need to be addressed by regulatory bodies like the Human Tissue Authority. Photopolymerization and Medical device manufacturers are using rapid prototyping to innovate, while healthcare professionals embrace the technology for prosthetics, surgical instruments, personalized prosthetics, orthotics, surgeon comfort, and fatigue prevention.

For more insights on driver and challenges – Request a sample report!

Segment Overview 

This 3d printing medical devices market report extensively covers market segmentation by  

Application 1.1 Orthopedic and spinal1.2 Dental1.3 Hearing aids1.4 OthersEnd-user 2.1 Hospitals and clinics2.2 Academic institutes2.3 Pharma and biotech companies2.4 OthersGeography 3.1 North America3.2 Europe3.3 Asia3.4 Rest of World (ROW)

1.1 Orthopedic and spinal-  The 3D printing medical devices market encompasses the production of orthopedic and spinal implants using 3D printing technology. This technology enables the fabrication of standard-sized implants, patient-matched implants, and custom implants for individuals with deformities. Hospitals and ambulatory surgery centers are major end-users, as 3D printing allows for the creation of complex structures and individualized implants. Orthopedic and spinal applications dominate the market due to the rising prevalence of related disorders, increasing demand for personalized implants, and the need for advanced surfaces and structures. The technology’s ability to manufacture lattice structures and porous surfaces promotes bone ingrowth and improves implant stability. Titanium implants, commonly used in orthopedics, benefit from 3D printing’s ability to create greater porosity, enhancing bony ingrowth and improving implant stability. In the field of prosthetics, 3D printing significantly reduces manufacturing time and costs while maintaining functionality. The technology’s affordability makes it particularly suitable for children who quickly outgrow their prosthetic limbs. Vendors are increasing investments in R&D to develop advanced orthopedic and spinal implants, further fueling market growth. Key factors driving the market include the aging population, increasing prevalence of orthopedic and spinal disorders, and the demand for customized implants. These factors are expected to propel the growth of the global 3D printing medical devices market during the forecast period.

For more information on market segmentation with geographical analysis including forecast (2024-2028) and historic data (2017-2021) – Download a Sample Report

Research Analysis

The 3D printing medical devices market is revolutionizing the healthcare industry by enabling the production of customized medical products in a layer-wise manner using CAD images. This technology allows for the creation of patient-specific products, including implants, hearing aids, bone scaffolds, surgical equipment, and more. The process begins with the creation of patient CAD images, which are then used to manufacture standard implants or personalized prosthetics, surgical instruments, and orthotics. The benefits of 3D printing in medical devices extend beyond patient comfort, as it also allows for the production of implantable and non-implantable medical devices using biomaterials, as well as drug testing and potential applications in organ transplantation and tissue engineering. Rapid prototyping and computer-aided manufacturing are key technologies driving the growth of this market, with healthcare professionals and medical device manufacturers embracing the technology to improve patient outcomes and surgical procedures.

Market Research Overview

The 3D printing medical devices market is revolutionizing the healthcare industry by enabling the production of customized medical products in a layer-wise manner using CAD images. This technology allows for the creation of patient-specific products such as implants, hearing aids, bone scaffolds, surgical equipment, and more. The use of patient CAD images ensures a perfect fit and optimal surgical outcomes, reducing operation time and post-surgical complications. 3D printing technology is being applied in various medical fields, including neurosurgery, orthopedics, and dentistry. For instance, it is used to create cranial implants, patient-specific models, and surgical tools for complex procedures. The use of biocompatible materials, such as titanium alloys and photopolymers, ensures the safety and effectiveness of 3D-printed medical devices. The market for 3D-printed medical devices is vast and diverse, encompassing elective surgical procedures, complex prosthetic limbs, brain designs, surgical instruments, and more. The technology is also being used in tissue engineering and organ transplantation, with the potential to print living cells and biomaterials. However, the use of 3D printing in medicine raises biosafety concerns and ethical issues, particularly with regard to the Human Tissue Authority and patient privacy. Medical device manufacturers are working to address these challenges through the use of CAD/CAM technology, rapid prototyping, and collaboration with healthcare professionals. The market for 3D-printed medical devices includes hearing aid manufacturers, dental clinics, hospitals, and surgical planning centers. The technology is also being used to create implantable and non-implantable medical devices, wearable medical devices, and diagnostic tools. The potential applications of 3D printing in medicine are vast, from surgical planning and dental restoration to remote patient monitoring and telemedicine. The future of medicine is undoubtedly 3D printed.

Table of Contents:

1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation

ApplicationOrthopedic And SpinalDentalHearing AidsOthersEnd-userHospitals And ClinicsAcademic InstitutesPharma And Biotech CompaniesOthersGeographyNorth AmericaEuropeAsiaRest Of World (ROW)

7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/3d-printing-medical-devices-market-size-is-set-to-grow-by-usd-7-07-billion-from-2024-2028–increased-demand-for-personalized-or-customized-medical-devices-boost-the-market-technavio-302209578.html

SOURCE Infiniti Research, Inc.

Continue Reading

Technology

Cognizant and Google Cloud Expand Alliance to Accelerate Agentic Enterprise Transformation

Published

on

By

Initiative establishes new Gemini Frontier Capability Group, dedicating more than 18,000 engineers to help drive AI adoption for global enterprises.More than 55,000 associates completed Build with Gemini, the largest Gemini partner workshop held to date, part of a shared commitment to scale client execution through Cognizant’s Frontier Certified Engineers.

TEANECK, N.J. and SUNNYVALE, Calif., Oct. 19, 2026 /PRNewswire/ — Cognizant (Nasdaq: CTSH) and Google Cloud today announced a significant expansion of their partnership to accelerate the adoption of agentic AI, including a new Gemini Frontier Capability Group. The group brings together a dedicated global workforce that pairs Google’s full-stack, enterprise-ready AI platform with Cognizant’s domain, industry and engineering expertise as an AI Builder.

Backed by more than 18,000 dedicated Cognizant associates, the new group represents a substantial joint investment and builds on the momentum created by Cognizant’s dedicated Gemini practice launched in April 2026. The new group is designed to bridge the path from pilot to production, equipping enterprises with the ability to safely deploy resilient, enterprise-grade agents that can help drive measurable business value.

“Establishing our dedicated Gemini Frontier Capability Group lets our best frontier engineering talent focus entirely on getting frontier AI into production for clients,” said Ravi Kumar S, CEO of Cognizant. “Our Build with Gemini workshop gave over 55,000 associates that experience directly, earning them tangible skills on one of the world’s most advanced AI platforms, and this new group is where that experience goes to work every day.”

“Deploying AI agents at scale requires trusted partners with deep architectural and integration expertise,” said Thomas Kurian, chief executive officer, Google Cloud. “Cognizant’s dedicated Frontier Capability Group and their skilling initiative for tens of thousands of engineers on Gemini will help our joint customers accelerate the adoption of autonomous agents throughout the enterprise.”

Introducing the Gemini Frontier Capability Group

Designed to meet surging enterprise demand for scaled AI execution, the group aims to deliver production-grade, AI solutions designed to drive business outcomes for global enterprises by leveraging Gemini, Google Cloud’s AI platform for building, governing, and deploying agents. The group will initially concentrate its engineering capabilities across legacy modernization, developer experience, autonomous business process agentification and frontier cyber defense.

To operationalize these capabilities, the group plans to deploy standardized, security-first agentic architecture built on the Model Context Protocol (MCP) and fortified by Google Cloud’s Model Armor. These trusted frameworks are expected to power a new suite of collaborative, production-ready enterprise solutions, including Cognizant’s Catalog Support Agent (CSA) for retail, the Neuro® San-orchestrated Healthcare Agentic Marketplace, and multi-agent Order-to-Cash (O2C) workflows for manufacturing.

Scaling outcomes with Frontier Certified Engineers

Underpinning the group is a shared commitment by Google Cloud and Cognizant to scale client execution through Frontier Certified Engineers. One early proof point shows what this looks like in practice: by integrating Gemini AI models across its software development lifecycle, Cognizant helped a leading retailer achieve a 40% increase in developer productivity, reduce time-to-market by 30%, and realize a 35% cost savings, underscoring the transformative potential of AI-driven software engineering.

As part of Cognizant’s frontier certification skills drive, the company recently concluded the Build with Gemini workshop with Google Cloud, where Cognizant associates built AI agents and applications while earning Gemini skills credentials. Completed by more than 55,000 Cognizant associates, it is the largest single Gemini partner workshop held to date, representing a meaningful step in building Cognizant’s frontier-certified workforce.

Cognizant is also applying Gemini internally at scale. As announced in July, the company is deploying Gemini to 100,000 associates this year, with plans to scale up to 200,000, and continues to increase its certification commitment for professionals on the platform.

About Cognizant
Cognizant (Nasdaq: CTSH) is an AI Builder and technology services provider, bridging the gap between AI investment and enterprise value by building full-stack AI solutions for our clients. Our deep industry, process and engineering expertise enables us to build an organization’s unique context into technology systems that amplify human potential, drive tangible outcomes and keep global enterprises ahead in a fast-changing world. See how at www.cognizant.ai or @cognizant. 

About Google Cloud
Google Cloud offers a powerful, optimized AI stack — including AI infrastructure, leading models like Gemini, data management capabilities, multicloud security solutions, developer tools and platform, as well as agents and applications — that enables organizations to transform their business for the Agentic Era. Customers in more than 200 countries and territories turn to Google Cloud as their trusted technology partner.

Cognizant media contacts:

U.S.

Name Ben Gorelick

Email benjamin.gorelick@cognizant.com 

Europe / APAC

Name Sarah Douglas

Email sarah.douglas@cognizant.com 

India

Name Vipin Nair

Email Vipin.nair@cognizant.com 

Google Cloud media contact:

   Josh Gunter

   jmgunter@google.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/cognizant-and-google-cloud-expand-alliance-to-accelerate-agentic-enterprise-transformation-302912036.html

SOURCE Cognizant Technology Solutions

Continue Reading

Technology

Eczema Awareness Month 2026: What Is the State of Eczema Today?

Published

on

By

NEA pairs findings from its State of AD report with video stories from the community to highlight the data and daily realities of living with eczema

For Eczema Awareness Month 2026, NEA asks what living with eczema looks like today, drawing on the State of AD to bring national data and personal stories together.

The State of Atopic Dermatitis Indicator Report and 51 state-level briefs, published Oct. 1, are available at StateofAD.org.

Video stories from people with eczema and their caregivers share what daily life with the condition is like. Join the conversation with #UnhideEczema.

NOVATO, Calif., Oct. 19, 2026 /PRNewswire/ — Eczema Awareness Month 2026 is underway, and this year’s theme is the State of Eczema. Since Oct. 1, the National Eczema Association (NEA) has been inviting the community to see, share and talk about what living with eczema is like. Throughout October, NEA is asking a question for the more than 31 million Americans living with eczema, and those who care for them: what is it like to live with eczema, and what does it take to get good care?

The theme builds on the State of AD, NEA’s four-year initiative on atopic dermatitis (AD), funded by the Centers for Disease Control and Prevention (CDC). It brings together two kinds of evidence, national data and the experiences of people with eczema, to offer a more complete view of the condition.

The State of AD: data that backs up the experience

On Oct. 1, NEA published its State of Atopic Dermatitis Indicator Report, along with 51 state-level briefs covering all 50 states and Washington, D.C. AD is the most common form of eczema. The report is the first comprehensive national and state-level baseline on AD diagnosis and care, and it points to gaps across the country. The complete report and all state briefs are available at StateofAD.org.

“Eczema Awareness Month is about making sure people feel seen. The State of AD gives us the evidence to show that eczema deserves attention in every state, and the stories our community is sharing show why it matters. Together, they tell the whole story,” said Kristin Belleson, president and CEO of NEA.

Video stories: eczema in their own words

Alongside the data, NEA is sharing video testimonials from people living with eczema and the caregivers who support them. The data shows the scale of the need, and the stories show the people behind it. Watch the stories at EczemaMonth.org.

Ways to take part this October

NEA invites people with eczema, caregivers, health care professionals and partners to join the conversation:

Watch and share the video stories from the eczema community.

Explore the State of AD report and your state’s brief at StateofAD.org.

Use #UnhideEczema on social media to share your own experience.

Visit EczemaMonth.org for resources, events and more ways to get involved.

NEA thanks all the sponsors and partners who make Eczema Awareness Month possible, including our Platinum Sponsors: AbbVie, all® free clear, LEO Pharma, and Sanofi and Regeneron.

Frequently Asked Questions (FAQ)

Q: What is Eczema Awareness Month?
A: Eczema Awareness Month takes place every October. In 2026, it is centered on the State of Eczema, bringing together national data and personal stories from the eczema community.

Q: What is the State of AD?
A: The State of AD is a four-year initiative funded by the CDC. Its foundation is the State of Atopic Dermatitis Indicator Report and 51 state-level briefs, published Oct. 1, which set a national and state reference baseline on AD care and diagnosed prevalence.

Q: Where can I find the State of AD report?
A: The full report and all state briefs are available at StateofAD.org.

Q: How can I take part in Eczema Awareness Month?
A: Watch and share the stories, explore the report and use #UnhideEczema on social media.

The State of AD project was supported by the Grant or Cooperative Agreement Number 1 NU58DP007726-01-00, funded by the Centers for Disease Control and Prevention (CDC). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention or the U.S. Department of Health and Human Services.

About the National Eczema Association

Founded in 1988, the National Eczema Association (NEA) is a 501(c)(3) nonprofit and the largest patient advocacy organization serving the more than 31 million Americans living with eczema and those who care for them. NEA provides programs and resources to elevate the diverse lived experience of eczema, helping patients and caregivers understand their condition, actively engage in their care, find strength in one another and improve their lives. NEA also advances critical eczema research and partners with key stakeholders to ensure the patient voice is represented and valued in education, care and treatment decision-making. Learn more: NationalEczema.org

View original content to download multimedia:https://www.prnewswire.com/news-releases/eczema-awareness-month-2026-what-is-the-state-of-eczema-today-302912799.html

SOURCE National Eczema Association

Continue Reading

Technology

In HelloNation, Electrical Expert Brennan Coffey Explains Why a Circuit Breaker Keeps Tripping

Published

on

By

The Article Explains Common Reasons a Circuit Breaker Trips and When the Pattern Signals a Bigger Problem.

SCHENECTADY, N.Y., Oct. 19, 2026 /PRNewswire/ — Why does a circuit breaker keep tripping? A HelloNation article answers that question and breaks down the most common reasons behind the problem.

The article explains that every circuit is built to carry a set amount of power safely. A circuit breaker cuts power once that limit is crossed, protecting the wiring from overheating before real damage occurs.

Each breaker in the panel protects one specific circuit, the article notes. An overloaded circuit will usually trip only its own breaker, not the entire panel. Homeowners often notice the pattern happens at predictable moments, like running a microwave and a toaster together.

According to the article, an overloaded circuit is one of the most common reasons a breaker trips. This often happens when several appliances draw power from the same outlets at once.

The article notes that kitchens are frequent trouble spots, since they run several high draw appliances from a limited number of outlets. Spreading large appliances across different circuits often solves the problem on its own.

A short circuit or a ground fault can also cause a circuit breaker to trip, the article explains, and both tend to act faster than a simple overload. A short circuit happens when a hot wire unexpectedly touches another wire.

A ground fault usually involves contact with a grounded surface, often because of moisture nearby. The article points out that GFCI outlets add protection in bathrooms and kitchens, though a standard breaker can still trip when a fault occurs elsewhere on the same circuit.

Newer homes may also have arc fault breakers, which sense the electrical pattern of an arc rather than a simple overload. These devices catch a hazard tied closely to house fires.

The article adds that an aging breaker can be the source of trouble in its own right, especially in a panel older than twenty years. Electrical Expert Brennan Coffey leads Coffey Electric & Generator, serving homeowners throughout the Schenectady area.

Homeowners should never open a panel cover or inspect breakers beyond resetting a switch, the article warns, since the panel carries live current even when a breaker has tripped. Forcing a stubborn breaker back on can let dangerous heat build inside the wall.

A breaker box that feels warm or shows scorch marks needs more urgency than routine tripping. That kind of heat points to trouble well beyond a simple overload, the article cautions.

The article suggests tracking when and where trips happen to spot a pattern before calling for help. Noting which appliances were running, and how often the issue repeats, gives a professional a useful starting point.

Waiting too long to address repeated trips can let a small issue grow into a larger and costlier one, the article explains. Addressing the pattern early tends to save both time and money down the road.

Electrical Expert Brennan Coffey is featured in the article, which advises against repeatedly resetting a breaker that keeps tripping without a clear cause. A licensed electrician can identify the underlying issue and determine what the repair actually requires.

Why Does a Circuit Breaker Keep Tripping? features insights from Brennan Coffey, Electrical Expert of Schenectady, New York, in HelloNation.

About HelloNation

HelloNation is America’s Good News Network, a premier media platform built on the idea that good news travels faster when real people tell real stories. Through its community-focused digital publications and innovative “edvertising” approach, HelloNation delivers expert-driven, good-news content that informs, inspires, and spotlights the leaders making a meaningful impact in their communities.

View original content to download multimedia:https://www.prnewswire.com/news-releases/in-hellonation-electrical-expert-brennan-coffey-explains-why-a-circuit-breaker-keeps-tripping-302912791.html

SOURCE HelloNation

Continue Reading

Trending